Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates
Open Access
- 8 November 2010
- journal article
- Published by Springer Nature in BMC Public Health
- Vol. 10 (1) , 679
Abstract
Diabetes mellitus (DM) is a major health problem in the United Arab Emirates (UAE) and is well recognized as a major and increasing burden to the country's resources due to its severe, long term debilitating effects on individuals, families and the society at large. The aim of the study was to estimate the direct annual treatment costs of DM and its related complications among patients in Al-Ain city, UAE.Keywords
This publication has 20 references indexed in Scilit:
- The Direct Economic Cost of Pharmacologically-Treated Diabetes in Italy-2006. The ARNO ObservatoryNutrition, Metabolism and Cardiovascular Diseases, 2010
- Direct Costs for Care and Glycaemic Control in Patients with Type 2 Diabetes in SudanExperimental and Clinical Endocrinology & Diabetes, 2010
- The economic costs of diabetes: a population-based study in Tehran, IranDiabetologia, 2009
- Economic Costs of Diabetes in the U.S. in 2007Diabetes Care, 2008
- Cost of diabetes care in out-patient clinics of Karachi, PakistanBMC Health Services Research, 2007
- Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional surveyBMC Ophthalmology, 2007
- The prevalence of macrovascular complications among diabetic patients in the United Arab EmiratesCardiovascular Diabetology, 2007
- The cost burden of diabetes mellitus: the evidence from Germany—the CoDiM StudyDiabetologia, 2006
- Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national surveyDiabetes Research and Clinical Practice, 2005
- Economic Costs of Disease and Injury: A Review of ConceptsPublic Health Reports (1896-1970), 1959